Mobilized peripheral blood CD34+ cells express more amphotropic retrovirus receptor than bone marrow CD34+ cells

Haematologica

Volumn 83, Issue 3, 1998, Pages 204-208

  Bregni, Marco ^a   Di Nicola, Massimo ^b   Siena, Salvatore ^b   Belli, Nadia ^b   Milanesi, Marco ^b   Shammah, Suzy ^b   Ravagnani, Fernando ^b   Gianni, Alessandro M ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b NONE

Author keywords

Amphotropic receptor; CD34; Gene transfer; Retroviruses; Stem cells

Indexed keywords

CD34 ANTIGEN; VIRUS RECEPTOR;

ARTICLE; BLOOD CELL; BONE MARROW CELL; CANCER PATIENT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; RECEPTOR BINDING; RETROVIRUS; VIRUS CELL INTERACTION;

ANTIGENS, CD34; BONE MARROW CELLS; CELLS, CULTURED; FLOW CYTOMETRY; GENETIC VECTORS; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; LEUKAPHERESIS; LEUKOCYTES; RECEPTORS, VIRUS; RETROVIRIDAE;

EID: 0031970589     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Mulligan RC. The basic science of gene therapy. Science 1993; 260:926.
2. Bregni M, Magni M, Siena S, et al. Human peripheral blood hematopoietic progenitors are optimal targets of retroviral-mediated gene transfer. Blood 1992; 80:1418-22.
3. Nolta JA, Smogorzewska EM, Kohn DB. Analysis of optimal conditions for retroviral-mediated transduction of primitive human hematopoietic cells. Blood 1995; 86:101-10.
4. van Zeijl M, Johann SV, Closs E, et al. A human amphotropic retrovirus receptor is a second member of the gibbon ape leukemia virus receptor family. Proc Natl Acad Sci USA 1994; 91:1168-72.
5. Evans LH, Morrison RP, Malik FG, et al. A neutralizable epitope common to the envelope glycoprotein of ecotropic, polytropic, xenotropic, and amphotropic murine leukemia viruses. J Virol 1990; 64:6176-83.
6. + bone marrow progenitor cells. Blood 1994; 82:3290-7.
7. Gianni AM, Bregni M, Siena S, et al. Recombinant human granulocyte-macrophage colony stimulating factor reduces hematologic toxicity and widens the clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma. J Clin Oncol 1990; 8:768-78.
8. Shammah S, Magni M, Schirò R, et al. Induction of cyclophosphamide resistance by aldehyde dehydrogenase gene transfer into hematopoietic cells. Gene Ther 1995; 2:(Suppl. 1)S12.
9. Orlic D, Girard LJ, Jordan CT, et al. The relative level of expression of retrovirus receptor mRNA in mouse and human primitive hematopoietic stem cells predicts the efficiency of gene transfer. Blood 1995; 86:628a.
10. Nolta JA, Kohn DB. Comparison of the effects of growth factors on retroviral vector-mediated gene transfer and the proliferative status of human hematopoietic progenitor cells. Hum Gene Ther 1990; 1:257-68.
11. Roberts AW, Metcalf D. Noncycling state of peripheral blood progenitor cells mobilized by granulocyte colony-stimulating factor and other cytokines. Blood 1995; 86:1600-5.
12. + cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor. Blood 1997; 89:1189-96.
13. Miller DG, Adam MA, Miller AD. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 1990; 10:4329-34.
14. Carlo Stella C, Tabilio A. Stem cells and stem cell transplantation. Haematologica 1996; 81:573-87.